Zemaira Related Clinical Trials
The Comparison of the Pharmacokinetic, Safety and Tolerability of Alpha-1 MP and Prolastin in Adult alpha1-Antitrypsin Deficient Patients. [Completed]
Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency [Completed]
Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients [Completed]
The Safety and Tolerability of Alpha-1 MP in Subjects With Alpha-1-Antitrypsin (AAT) Deficiency. [Completed]
Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency [Completed]
Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor (API) Deficiency [Recruiting]
Study of Zemaira i.v. Administration in Subjects Who Completed a 2-Year Controlled Study With This Treatment and Have Emphysema Due to alpha1 -Proteinase Inhibitor Deficiency. [Recruiting]
Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals [Completed]
Efficacy and Safety Study of Augmentation Therapy With Aralast (Human Alpha 1 - Proteinase Inhibitor) [Completed]
Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency [Completed]
Pharmacokinetic Study of Aralast (Human Alpha1- PI) [Completed]
Aralast alpha1-Proteinase Inhibitor Surveillance Study [Active, not recruiting]
The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency [Recruiting]
Alpha-1 Coded Testing Study (ACT Trial) [Recruiting]
Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin Deficiency [Active, not recruiting]
Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin Deficiency [Active, not recruiting]
Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency [Terminated]
Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema [Recruiting]
Alpha1-Antitrypsin Deficiency Registry [Completed]
4-PBA: Will It Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency? [Active, not recruiting]
Deposition of Inhaled Prolastin in Cystic Fibrosis Patients [Completed]
Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients [Recruiting]
Alpha-1 Foundation Research Registry [Recruiting]
Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases [Recruiting]
Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis [Completed]
Role of Genetic Factors in the Development of Lung Disease [Recruiting]
Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis [Completed]
Genetic and Environmental Risk Factors for Hemorrhagic Stroke [Completed]
|
